Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.62
-0.0700-4.14%
Post-market: 1.670.0487+3.01%16:14 EDT
Volume:2.83M
Turnover:4.69M
Market Cap:99.20M
PE:-0.47
High:1.70
Open:1.66
Low:1.60
Close:1.69
Loading ...

Pliant Therapeutics Inc: Pln-101095 Was Generally Well Tolerated Across All Doses

THOMSON REUTERS
·
17 Mar

Pliant Therapeutics Signs Shareholder Rights Agreement

MT Newswires Live
·
13 Mar

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

THOMSON REUTERS
·
13 Mar

Pliant Therapeutics- Agreement to Reduce Likelihood Any Entity, Person, Group Able to Gain Control of Co Through Open Market Accumulation

THOMSON REUTERS
·
13 Mar

Needham Downgrades Pliant Therapeutics to Hold From Buy

MT Newswires Live
·
04 Mar

Analysts Conflicted on These Healthcare Names: Pliant Therapeutics (PLRX) and Capricor Therapeutics (CAPR)

TIPRANKS
·
04 Mar

Pliant Therapeutics Cut to Hold From Buy by Needham

Dow Jones
·
04 Mar

RBC Cuts Price Target on Pliant Therapeutics to $3 From $4, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
04 Mar

RBC Capital Reaffirms Their Hold Rating on Pliant Therapeutics (PLRX)

TIPRANKS
·
04 Mar

Wells Fargo Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)

TIPRANKS
·
04 Mar

Pliant Therapeutics, Inc. : Wells Fargo Cuts Target Price to $3 From $4

THOMSON REUTERS
·
04 Mar

Pliant Therapeutics Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $2 From $33

THOMSON REUTERS
·
04 Mar

Pliant Therapeutics Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
04 Mar

Pliant Therapeutics Q4 2024 GAAP EPS $(0.82) Beats $(0.98) Estimate

Benzinga
·
04 Mar

BRIEF-Pliant Therapeutics Q4 Net Income USD -49.732 Million

Reuters
·
04 Mar

Pliant Therapeutics Q4 Net Income USD -49.732 Million

THOMSON REUTERS
·
04 Mar